Evidence for a true post-β-lactamase-inhibitor effect of clavulanic acid against Klebsiella pneumoniae and Haemophilus influenzae
The purpose of this study was to investigate and characterize in vitro the post-β-lactamase inhibitor effect (PLIE) of clavulanic acid against two β-lactamase-producing species of bacteria. The PLIE was investigated against one strain of Klebsiella pneumoniae and one strain of Haemophilus influenzae...
Gespeichert in:
Veröffentlicht in: | Clinical microbiology and infection 2001-12, Vol.7 (12), p.661-665 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 665 |
---|---|
container_issue | 12 |
container_start_page | 661 |
container_title | Clinical microbiology and infection |
container_volume | 7 |
creator | Murbach, V. Dhoyen, N. Linger, L. Monteil, H. Jehl, F. |
description | The purpose of this study was to investigate and characterize in vitro the post-β-lactamase inhibitor effect (PLIE) of clavulanic acid against two β-lactamase-producing species of bacteria.
The PLIE was investigated against one strain of Klebsiella pneumoniae and one strain of Haemophilus influenzae. A stationary-phase inoculum of about 107 colony-forming units per mL of each bacterium was pre-exposed for 2 h to clavulanic acid, either alone or in combination with amoxicillin at various concentrations. After pre-exposure, the dilution required to remove the β-lactamase inhibitor was 1:100 or 1:1000 according to the bacterial species and their susceptibilities to clavulanic acid. Bacteria were counted hourly after drug removal, on solid agar medium.
Control cultures exposed to amoxicillin alone after dilution, showed a delay in growth, which may be inherent to the time required to synthesize sufficient β-lactamase after the dilution steps. Control experiments clearly distinguished the post-antibiotic effect and the growth delay from the PLIE.
The PLIE could be one of several factors explaining why β-lactam/β-lactamase inhibitor combinations remain effective throughout the dosing interval, even if a few hours after in vivo administration, serum concentrations of β-lactamase inhibitor fall below levels that are active in vitro. |
doi_str_mv | 10.1046/j.1469-0691.2001.00336.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72439658</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1198743X14641069</els_id><sourcerecordid>106792956</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5336-7b017d684a98c3f188fc358e1b0427dec07ee08d9b8e02ae6eaec6a93e7f66fd3</originalsourceid><addsrcrecordid>eNqNksGOFCEQhjtG466rr2CIB-OlW2h6gE68uJPVNY7xook3QkPhMqFhhO5x16OP5IP4TNLORBMP6gkSvr9SVR9VhQhuCO7Y021DOtbXmPWkaTEmDcaUsub6VnX66-F2uZNe1LyjH06qezlvMcYtpd3d6oQQ0dEes9Pq68XeGQgakI0JKTSlGdAu5qn-_q32Sk9qVBlqF67c4KaCgLWgJxQt0l7tZ6-C00hpZ5D6qFzIE3rtYcgOvFdoF2AeY3AKkAoGXSoY4-7K-TkjF6yfIXxRcL-6Y5XP8OB4nlXvX1y8W1_Wm7cvX62fb2q9KsPVfMCEGyY61QtNLRHCaroSQAbctdyAxhwAC9MPAnCrgIECzVRPgVvGrKFn1eND3V2Kn2bIkxxd1kufAeKcJW_LTthKFPDJX0HCBGecCrIq6KM_0G2cUyhjyLYlHLeltQKJA6RTzDmBlbvkRpVuJMFy8Sm3ctEmF21y8Sl_-pTXJfrwWH8eRjC_g0eBBXh2AD47Dzf_XViuN2_KpcTPD3Eoi987SDJrt3wH41LRLE10_27yB0ntxhc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221702427</pqid></control><display><type>article</type><title>Evidence for a true post-β-lactamase-inhibitor effect of clavulanic acid against Klebsiella pneumoniae and Haemophilus influenzae</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>ProQuest Central UK/Ireland</source><source>Alma/SFX Local Collection</source><creator>Murbach, V. ; Dhoyen, N. ; Linger, L. ; Monteil, H. ; Jehl, F.</creator><creatorcontrib>Murbach, V. ; Dhoyen, N. ; Linger, L. ; Monteil, H. ; Jehl, F.</creatorcontrib><description>The purpose of this study was to investigate and characterize in vitro the post-β-lactamase inhibitor effect (PLIE) of clavulanic acid against two β-lactamase-producing species of bacteria.
The PLIE was investigated against one strain of Klebsiella pneumoniae and one strain of Haemophilus influenzae. A stationary-phase inoculum of about 107 colony-forming units per mL of each bacterium was pre-exposed for 2 h to clavulanic acid, either alone or in combination with amoxicillin at various concentrations. After pre-exposure, the dilution required to remove the β-lactamase inhibitor was 1:100 or 1:1000 according to the bacterial species and their susceptibilities to clavulanic acid. Bacteria were counted hourly after drug removal, on solid agar medium.
Control cultures exposed to amoxicillin alone after dilution, showed a delay in growth, which may be inherent to the time required to synthesize sufficient β-lactamase after the dilution steps. Control experiments clearly distinguished the post-antibiotic effect and the growth delay from the PLIE.
The PLIE could be one of several factors explaining why β-lactam/β-lactamase inhibitor combinations remain effective throughout the dosing interval, even if a few hours after in vivo administration, serum concentrations of β-lactamase inhibitor fall below levels that are active in vitro.</description><identifier>ISSN: 1198-743X</identifier><identifier>EISSN: 1469-0691</identifier><identifier>DOI: 10.1046/j.1469-0691.2001.00336.x</identifier><identifier>PMID: 11843906</identifier><language>eng</language><publisher>Oxford, UK: Elsevier Ltd</publisher><subject>Amoxicillin - pharmacology ; Anti-Bacterial Agents - pharmacology ; beta-Lactamase Inhibitors ; beta-Lactamases - biosynthesis ; Clavulanic acid ; Clavulanic Acid - pharmacology ; Haemophilus influenzae ; Haemophilus influenzae - drug effects ; Haemophilus influenzae - enzymology ; Haemophilus influenzae - growth & development ; Humans ; Klebsiella pneumoniae ; Klebsiella pneumoniae - drug effects ; Klebsiella pneumoniae - enzymology ; Klebsiella pneumoniae - growth & development ; Microbial Sensitivity Tests ; Penicillins - pharmacology ; post-β-lactamase inhibitor effect ; β-lactamases</subject><ispartof>Clinical microbiology and infection, 2001-12, Vol.7 (12), p.661-665</ispartof><rights>2001 European Society of Clinical Infectious Diseases</rights><rights>Copyright Decker Periodicals, Inc. Dec 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5336-7b017d684a98c3f188fc358e1b0427dec07ee08d9b8e02ae6eaec6a93e7f66fd3</citedby><cites>FETCH-LOGICAL-c5336-7b017d684a98c3f188fc358e1b0427dec07ee08d9b8e02ae6eaec6a93e7f66fd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1469-0691.2001.00336.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/221702427?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11843906$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Murbach, V.</creatorcontrib><creatorcontrib>Dhoyen, N.</creatorcontrib><creatorcontrib>Linger, L.</creatorcontrib><creatorcontrib>Monteil, H.</creatorcontrib><creatorcontrib>Jehl, F.</creatorcontrib><title>Evidence for a true post-β-lactamase-inhibitor effect of clavulanic acid against Klebsiella pneumoniae and Haemophilus influenzae</title><title>Clinical microbiology and infection</title><addtitle>Clin Microbiol Infect</addtitle><description>The purpose of this study was to investigate and characterize in vitro the post-β-lactamase inhibitor effect (PLIE) of clavulanic acid against two β-lactamase-producing species of bacteria.
The PLIE was investigated against one strain of Klebsiella pneumoniae and one strain of Haemophilus influenzae. A stationary-phase inoculum of about 107 colony-forming units per mL of each bacterium was pre-exposed for 2 h to clavulanic acid, either alone or in combination with amoxicillin at various concentrations. After pre-exposure, the dilution required to remove the β-lactamase inhibitor was 1:100 or 1:1000 according to the bacterial species and their susceptibilities to clavulanic acid. Bacteria were counted hourly after drug removal, on solid agar medium.
Control cultures exposed to amoxicillin alone after dilution, showed a delay in growth, which may be inherent to the time required to synthesize sufficient β-lactamase after the dilution steps. Control experiments clearly distinguished the post-antibiotic effect and the growth delay from the PLIE.
The PLIE could be one of several factors explaining why β-lactam/β-lactamase inhibitor combinations remain effective throughout the dosing interval, even if a few hours after in vivo administration, serum concentrations of β-lactamase inhibitor fall below levels that are active in vitro.</description><subject>Amoxicillin - pharmacology</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>beta-Lactamase Inhibitors</subject><subject>beta-Lactamases - biosynthesis</subject><subject>Clavulanic acid</subject><subject>Clavulanic Acid - pharmacology</subject><subject>Haemophilus influenzae</subject><subject>Haemophilus influenzae - drug effects</subject><subject>Haemophilus influenzae - enzymology</subject><subject>Haemophilus influenzae - growth & development</subject><subject>Humans</subject><subject>Klebsiella pneumoniae</subject><subject>Klebsiella pneumoniae - drug effects</subject><subject>Klebsiella pneumoniae - enzymology</subject><subject>Klebsiella pneumoniae - growth & development</subject><subject>Microbial Sensitivity Tests</subject><subject>Penicillins - pharmacology</subject><subject>post-β-lactamase inhibitor effect</subject><subject>β-lactamases</subject><issn>1198-743X</issn><issn>1469-0691</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNksGOFCEQhjtG466rr2CIB-OlW2h6gE68uJPVNY7xook3QkPhMqFhhO5x16OP5IP4TNLORBMP6gkSvr9SVR9VhQhuCO7Y021DOtbXmPWkaTEmDcaUsub6VnX66-F2uZNe1LyjH06qezlvMcYtpd3d6oQQ0dEes9Pq68XeGQgakI0JKTSlGdAu5qn-_q32Sk9qVBlqF67c4KaCgLWgJxQt0l7tZ6-C00hpZ5D6qFzIE3rtYcgOvFdoF2AeY3AKkAoGXSoY4-7K-TkjF6yfIXxRcL-6Y5XP8OB4nlXvX1y8W1_Wm7cvX62fb2q9KsPVfMCEGyY61QtNLRHCaroSQAbctdyAxhwAC9MPAnCrgIECzVRPgVvGrKFn1eND3V2Kn2bIkxxd1kufAeKcJW_LTthKFPDJX0HCBGecCrIq6KM_0G2cUyhjyLYlHLeltQKJA6RTzDmBlbvkRpVuJMFy8Sm3ctEmF21y8Sl_-pTXJfrwWH8eRjC_g0eBBXh2AD47Dzf_XViuN2_KpcTPD3Eoi987SDJrt3wH41LRLE10_27yB0ntxhc</recordid><startdate>200112</startdate><enddate>200112</enddate><creator>Murbach, V.</creator><creator>Dhoyen, N.</creator><creator>Linger, L.</creator><creator>Monteil, H.</creator><creator>Jehl, F.</creator><general>Elsevier Ltd</general><general>Blackwell Science, Ltd</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FQ</scope><scope>8FV</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M3G</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7T2</scope><scope>7U2</scope><scope>7X8</scope></search><sort><creationdate>200112</creationdate><title>Evidence for a true post-β-lactamase-inhibitor effect of clavulanic acid against Klebsiella pneumoniae and Haemophilus influenzae</title><author>Murbach, V. ; Dhoyen, N. ; Linger, L. ; Monteil, H. ; Jehl, F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5336-7b017d684a98c3f188fc358e1b0427dec07ee08d9b8e02ae6eaec6a93e7f66fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Amoxicillin - pharmacology</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>beta-Lactamase Inhibitors</topic><topic>beta-Lactamases - biosynthesis</topic><topic>Clavulanic acid</topic><topic>Clavulanic Acid - pharmacology</topic><topic>Haemophilus influenzae</topic><topic>Haemophilus influenzae - drug effects</topic><topic>Haemophilus influenzae - enzymology</topic><topic>Haemophilus influenzae - growth & development</topic><topic>Humans</topic><topic>Klebsiella pneumoniae</topic><topic>Klebsiella pneumoniae - drug effects</topic><topic>Klebsiella pneumoniae - enzymology</topic><topic>Klebsiella pneumoniae - growth & development</topic><topic>Microbial Sensitivity Tests</topic><topic>Penicillins - pharmacology</topic><topic>post-β-lactamase inhibitor effect</topic><topic>β-lactamases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murbach, V.</creatorcontrib><creatorcontrib>Dhoyen, N.</creatorcontrib><creatorcontrib>Linger, L.</creatorcontrib><creatorcontrib>Monteil, H.</creatorcontrib><creatorcontrib>Jehl, F.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Canadian Business & Current Affairs Database</collection><collection>Canadian Business & Current Affairs Database (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>CBCA Reference & Current Events</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Safety Science and Risk</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical microbiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murbach, V.</au><au>Dhoyen, N.</au><au>Linger, L.</au><au>Monteil, H.</au><au>Jehl, F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evidence for a true post-β-lactamase-inhibitor effect of clavulanic acid against Klebsiella pneumoniae and Haemophilus influenzae</atitle><jtitle>Clinical microbiology and infection</jtitle><addtitle>Clin Microbiol Infect</addtitle><date>2001-12</date><risdate>2001</risdate><volume>7</volume><issue>12</issue><spage>661</spage><epage>665</epage><pages>661-665</pages><issn>1198-743X</issn><eissn>1469-0691</eissn><abstract>The purpose of this study was to investigate and characterize in vitro the post-β-lactamase inhibitor effect (PLIE) of clavulanic acid against two β-lactamase-producing species of bacteria.
The PLIE was investigated against one strain of Klebsiella pneumoniae and one strain of Haemophilus influenzae. A stationary-phase inoculum of about 107 colony-forming units per mL of each bacterium was pre-exposed for 2 h to clavulanic acid, either alone or in combination with amoxicillin at various concentrations. After pre-exposure, the dilution required to remove the β-lactamase inhibitor was 1:100 or 1:1000 according to the bacterial species and their susceptibilities to clavulanic acid. Bacteria were counted hourly after drug removal, on solid agar medium.
Control cultures exposed to amoxicillin alone after dilution, showed a delay in growth, which may be inherent to the time required to synthesize sufficient β-lactamase after the dilution steps. Control experiments clearly distinguished the post-antibiotic effect and the growth delay from the PLIE.
The PLIE could be one of several factors explaining why β-lactam/β-lactamase inhibitor combinations remain effective throughout the dosing interval, even if a few hours after in vivo administration, serum concentrations of β-lactamase inhibitor fall below levels that are active in vitro.</abstract><cop>Oxford, UK</cop><pub>Elsevier Ltd</pub><pmid>11843906</pmid><doi>10.1046/j.1469-0691.2001.00336.x</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1198-743X |
ispartof | Clinical microbiology and infection, 2001-12, Vol.7 (12), p.661-665 |
issn | 1198-743X 1469-0691 |
language | eng |
recordid | cdi_proquest_miscellaneous_72439658 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals; ProQuest Central UK/Ireland; Alma/SFX Local Collection |
subjects | Amoxicillin - pharmacology Anti-Bacterial Agents - pharmacology beta-Lactamase Inhibitors beta-Lactamases - biosynthesis Clavulanic acid Clavulanic Acid - pharmacology Haemophilus influenzae Haemophilus influenzae - drug effects Haemophilus influenzae - enzymology Haemophilus influenzae - growth & development Humans Klebsiella pneumoniae Klebsiella pneumoniae - drug effects Klebsiella pneumoniae - enzymology Klebsiella pneumoniae - growth & development Microbial Sensitivity Tests Penicillins - pharmacology post-β-lactamase inhibitor effect β-lactamases |
title | Evidence for a true post-β-lactamase-inhibitor effect of clavulanic acid against Klebsiella pneumoniae and Haemophilus influenzae |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T16%3A32%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evidence%20for%20a%20true%20post-%CE%B2-lactamase-inhibitor%20effect%20of%20clavulanic%20acid%20against%20Klebsiella%20pneumoniae%20and%20Haemophilus%20influenzae&rft.jtitle=Clinical%20microbiology%20and%20infection&rft.au=Murbach,%20V.&rft.date=2001-12&rft.volume=7&rft.issue=12&rft.spage=661&rft.epage=665&rft.pages=661-665&rft.issn=1198-743X&rft.eissn=1469-0691&rft_id=info:doi/10.1046/j.1469-0691.2001.00336.x&rft_dat=%3Cproquest_cross%3E106792956%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=221702427&rft_id=info:pmid/11843906&rft_els_id=S1198743X14641069&rfr_iscdi=true |